XBiotech
XBIT
$7.87
Share price
-4.14%
Change (1 day)
140.67%
Change (1 year)
Categories
XBiotech (XBIT) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $7.76 M
According to XBiotech's latest financial reports the company's total liabilities are $7.76 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
XBiotech - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $5.7 M | -1.57% |
| 2021-12-31 | $5.79 M | 13.46% |
| 2020-12-31 | $5.1 M | -91.66% |
| 2019-12-31 | $61.24 M | 1978.25% |
| 2018-12-31 | $2.94 M | 4.88% |
| 2017-12-31 | $2.81 M | -64.81% |
| 2016-12-31 | $7.98 M | 26.6% |
| 2015-12-31 | $6.3 M | 100.44% |
| 2014-12-31 | $3.14 M | 272.43% |
| 2013-12-31 | $0.84 M | -22.97% |
| 2012-12-31 | $1.09 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 uniQure QURE | $0.62 B | 7,932.17% | 🇳🇱 Netherlands |
 Calithera Biosciences
CALA | $8.28 M | 6.63% | 🇺🇸 USA |
 Enzo Biochem ENZ | $28.3 M | 264.29% | 🇺🇸 USA |